Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 215

Related Articles by Review for PubMed (Select 12721241)

1.

Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.

Meijers-Heijboer H, Brekelmans CT, Menke-Pluymers M, Seynaeve C, Baalbergen A, Burger C, Crepin E, van den Ouweland AW, van Geel B, Klijn JG.

J Clin Oncol. 2003 May 1;21(9):1675-81.

PMID:
12721241
2.

Family history as a predictor of uptake of cancer preventive procedures by women with a BRCA1 or BRCA2 mutation.

Metcalfe KA, Foulkes WD, Kim-Sing C, Ainsworth P, Rosen B, Armel S, Poll A, Eisen A, Gilchrist D, Chudley A, Ghadirian P, Maugard C, Lemire EG, Sun P, Narod SA.

Clin Genet. 2008 May;73(5):474-9. doi: 10.1111/j.1399-0004.2008.00988.x. Epub 2008 Mar 12. Review.

PMID:
18341607
3.

Prophylactic surgery for women at high risk for breast cancer.

Blanchard DK, Hartmann LC.

Clin Breast Cancer. 2000 Jul;1(2):127-34; discussion 135. Review.

PMID:
11899651
4.

Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature.

Calderon-Margalit R, Paltiel O.

Int J Cancer. 2004 Nov 10;112(3):357-64. Review.

PMID:
15382059
5.

[Genetic test and prophylactic treatment in breast cancer families].

Miyoshi Y, Noguchi S.

Gan To Kagaku Ryoho. 2002 Apr;29(4):512-22. Review. Japanese.

PMID:
11977534
6.

Breast cancer and ovarian cancer genetics.

Edlich RF, Winters KL, Lin KY.

J Long Term Eff Med Implants. 2005;15(5):533-45. Review.

PMID:
16218901
7.

Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.

Kuschel B, Lux MP, Goecke TO, Beckmann MW.

Eur J Cancer Prev. 2000 Jun;9(3):139-50. Review.

PMID:
10954253
8.

Management updates for women with a BRCA1 or BRCA2 mutation.

Nusbaum R, Isaacs C.

Mol Diagn Ther. 2007;11(3):133-44. Review.

PMID:
17570734
9.

Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers.

Rebbeck TR.

J Clin Oncol. 2000 Nov 1;18(21 Suppl):100S-3S. Review.

PMID:
11060335
10.

Prophylactic mastectomy and genetic testing: an update.

Houshmand SL, Campbell CT, Briggs SE, McFadden AW, Al-Tweigeri T.

Oncol Nurs Forum. 2000 Nov-Dec;27(10):1537-47; quiz 1548-9. Review.

PMID:
11103373
11.

Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.

Casey MJ, Bewtra C, Hoehne LL, Tatpati AD, Lynch HT, Watson P.

Gynecol Oncol. 2000 Sep;78(3 Pt 1):278-87. Review.

PMID:
10985881
12.

Prophylactic bilateral mastectomy for breast cancer prevention.

Metcalfe KA.

J Womens Health (Larchmt). 2004 Sep;13(7):822-9. Review.

PMID:
15385076
13.

Clinical management of women with genomic BRCA1 and BRCA2 mutations.

Chang J, Elledge RM.

Breast Cancer Res Treat. 2001 Sep;69(2):101-13. Review.

PMID:
11759816
14.

Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation.

Wainberg S, Husted J.

Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):1989-95. Review.

15.

Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention.

S√łgaard M, Kjaer SK, Gayther S.

Acta Obstet Gynecol Scand. 2006;85(1):93-105. Review.

PMID:
16521688
16.

The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations.

Fatouros M, Baltoyiannis G, Roukos DH.

Ann Surg Oncol. 2008 Jan;15(1):21-33. Epub 2007 Oct 17. Review.

PMID:
17940826
17.

Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.

Roukos DH, Briasoulis E.

Nat Clin Pract Oncol. 2007 Oct;4(10):578-90. Review.

PMID:
17898808
18.

Educational review: role of the surgeon in hereditary breast cancer.

Newman LA, Kuerer HM, Hunt KK, Vlastos G, Ames FC, Ross MI, Singletary SE.

Ann Surg Oncol. 2001 May;8(4):368-78. Review.

PMID:
11352312
19.

Hereditary breast cancer and handling of patients at risk.

Eerola H, Aittomäki K, Asko-Seljavaara S, Nevanlinna H, von Smitten K.

Scand J Surg. 2002;91(3):280-7. Review.

PMID:
12449472
20.

Breast cancer genetics in African Americans.

Olopade OI, Fackenthal JD, Dunston G, Tainsky MA, Collins F, Whitfield-Broome C.

Cancer. 2003 Jan 1;97(1 Suppl):236-45. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk